Department of Oncology-Pathology
The Department of Oncology-Pathology conducts basic, translational and clinical research and educational activities related to cancer.
Menu for this area
Photo: Ioanna Markaki, Ingvild Festervold MelienNew professors at OnkPat
We congratulate Theodoros Foukakis appointed as professor from April 2, 2025. We also congratulate Lars A. Akslen appointed as foreign adjunct professor at OnkPat from April 1, 2025.
Photo: N/ADose-dense chemotherapy improves survival for breast cancer patients
Alexios Matikas and Theodoros Foukakis have published a secondary analysis of the phase 3 PANTHER study in Lancet Regional Health Europe, showing that all patients with operated, lymph node-positive breast cancer benefit from more frequent chemotherapy every two weeks compared to the standard treatment every three weeks.
Photo: Stefan ZimmermanThuy Tran receives grant from Erling-Persson Foundation to develop method for hard-to-treat cancer
Thuy Tran’s research group has been awarded 8 million SEK over three years from the Erling-Persson Foundation to develop a precision-focused, theranostic method that integrates both diagnostics and treatment of advanced solid tumors. Thuy Tran’s research focuses on creating an innovative, targeted platform that aims to provide less invasive, personalized, and targeted treatment options. The goal is to improve both patient well-being and treatment outcomes.
Photo: Erika RindsjöNew study reveals how mitochondria change during egg cell maturation
In a study published in Biomarkers Research, Kenny Rodriguez-Wallberg, Xia Hao, and Jian Zhao investigate how mitochondria change from being evenly distributed to forming clusters during the maturation of mouse egg cells, providing a new method for evaluating egg cell health.
News and calendar from OnkPat
Related centers
Photo: Creative Commons CC0Cancer Research KI
Cancer Research KI is an overarching umbrella organisation and single point of entry to cancer research at Karolinska Institutet, that includes some 250 research groups. The aim is to bring together top-level cancer scientists from different disciplines, with the overall goal to generate new discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.
Photo: Angiola HarryBRECT - Breast Cancer Theme Center
BRECT aims to increase our understanding of critical steps in breast cancer development and therapy.
KIPCM - The Personalised Cancer Medicine Program
The Personalised Cancer Medicine Program at Karolinska Institutet (KIPCM) is a research initiative with the primary task to strengthen the infrastructure for team science addressing PCM. The core of the work is to bring together researchers at KI and SciLifeLab with clinical researchers at Karolinska University Hospital for PCM team science.
Photo: n/aCancer Core Europe
Karolinska Institutet is one of the seven leading cancer centers that have joined forces to form the European cancer association Cancer Core Europe.
KI operational delegate: Christina von Gertten